Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1.

Costigan M, Belfer I, Griffin RS, Dai F, Barrett LB, Coppola G, Wu T, Kiselycznyk C, Poddar M, Lu Y, Diatchenko L, Smith S, Cobos EJ, Zaykin D, Allchorne A, Gershon E, Livneh J, Shen PH, Nikolajsen L, Karppinen J, Männikkö M, Kelempisioti A, Goldman D, Maixner W, Geschwind DH, Max MB, Seltzer Z, Woolf CJ.

Brain. 2010 Sep;133(9):2519-27. doi: 10.1093/brain/awq195. Epub 2010 Aug 18. Erratum in: Brain. 2011 Jul;134(7):2186. Gershon, Edith [added]; Livneh, Jessica [added].

2.

Linkage of large-vessel carotid atherosclerotic stroke to inflammatory genes via a systematic screen.

Belfer I, Wu T, Hipp H, Walter J, Scully M, Nyquist PA, Bollettino A, Goldman D, Max MB, DeGraba TJ.

Int J Stroke. 2010 Jun;5(3):145-51. doi: 10.1111/j.1747-4949.2010.00422.x.

3.

Pain perception is altered by a nucleotide polymorphism in SCN9A.

Reimann F, Cox JJ, Belfer I, Diatchenko L, Zaykin DV, McHale DP, Drenth JP, Dai F, Wheeler J, Sanders F, Wood L, Wu TX, Karppinen J, Nikolajsen L, Männikkö M, Max MB, Kiselycznyk C, Poddar M, Te Morsche RH, Smith S, Gibson D, Kelempisioti A, Maixner W, Gribble FM, Woods CG.

Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5148-53. doi: 10.1073/pnas.0913181107. Epub 2010 Mar 8.

4.

Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2).

Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R.

Pain. 2009 Jul;144(1-2):35-42. doi: 10.1016/j.pain.2009.02.007. Epub 2009 Apr 7.

PMID:
19356853
5.

A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.

Dworkin RH, Barbano RL, Tyring SK, Betts RF, McDermott MP, Pennella-Vaughan J, Bennett GJ, Berber E, Gnann JW, Irvine C, Kamp C, Kieburtz K, Max MB, Schmader KE.

Pain. 2009 Apr;142(3):209-17. doi: 10.1016/j.pain.2008.12.022. Epub 2009 Feb 4.

PMID:
19195785
6.

Expansion of the human mu-opioid receptor gene architecture: novel functional variants.

Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L.

Hum Mol Genet. 2009 Mar 15;18(6):1037-51. doi: 10.1093/hmg/ddn439. Epub 2008 Dec 22.

7.

Addressing the decline in NIH pain research funding.

Max MB.

J Pain. 2008 Dec;9(12):1074-6. doi: 10.1016/j.jpain.2008.10.001. No abstract available.

PMID:
19038769
8.

Does the pain-protective GTP cyclohydrolase haplotype significantly alter the pattern or severity of pain in humans with chronic pancreatitis?

Lazarev M, Lamb J, Barmada MM, Dai F, Anderson MA, Max MB, Whitcomb DC.

Mol Pain. 2008 Nov 17;4:58. doi: 10.1186/1744-8069-4-58.

9.

Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials.

Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, Cleeland CS, Cowan P, Dimitrova R, Farrar JT, Hertz S, Heyse JF, Iyengar S, Jadad AR, Jay GW, Jermano JA, Katz NP, Manning DC, Martin S, Max MB, McGrath P, McQuay HJ, Quessy S, Rappaport BA, Revicki DA, Rothman M, Stauffer JW, Svensson O, White RE, Witter J.

Pain. 2008 Oct 31;139(3):485-93. doi: 10.1016/j.pain.2008.06.025. Epub 2008 Aug 15. Review.

PMID:
18706763
10.

Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial.

Wu CL, Agarwal S, Tella PK, Klick B, Clark MR, Haythornthwaite JA, Max MB, Raja SN.

Anesthesiology. 2008 Aug;109(2):289-96. doi: 10.1097/ALN.0b013e31817f4523.

11.

The molecular epidemiology of pain: a new discipline for drug discovery.

Max MB, Stewart WF.

Nat Rev Drug Discov. 2008 Aug;7(8):647-58. doi: 10.1038/nrd2595. Epub 2008 Jun 27. Review.

PMID:
18587382
12.

Influence of psychological factors on risk of temporomandibular disorders.

Slade GD, Diatchenko L, Bhalang K, Sigurdsson A, Fillingim RB, Belfer I, Max MB, Goldman D, Maixner W.

J Dent Res. 2007 Nov;86(11):1120-5.

PMID:
17959908
13.

Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.

Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, Cleeland CS, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA.

Pain. 2008 Jul 15;137(2):276-85. Epub 2007 Oct 15.

PMID:
17937976
14.

Do motor control genes contribute to interindividual variability in decreased movement in patients with pain?

Mishra BK, Wu T, Belfer I, Hodgkinson CA, Cohen LG, Kiselycznyk C, Kingman A, Keller RB, Yuan Q, Goldman D, Atlas SJ, Max MB.

Mol Pain. 2007 Jul 26;3:20.

15.

Low intensity permanent magnets in the treatment of chronic lumbar radicular pain.

Khoromi S, Blackman MR, Kingman A, Patsalides A, Matheny LA, Adams S, Pilla AA, Max MB.

J Pain Symptom Manage. 2007 Oct;34(4):434-45. Epub 2007 Jul 9.

PMID:
17618081
16.

Reliable screening for a pain-protective haplotype in the GTP cyclohydrolase 1 gene (GCH1) through the use of 3 or fewer single nucleotide polymorphisms.

Lötsch J, Belfer I, Kirchhof A, Mishra BK, Max MB, Doehring A, Costigan M, Woolf CJ, Geisslinger G, Tegeder I.

Clin Chem. 2007 Jun;53(6):1010-5. Epub 2007 Mar 15.

17.

Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain.

Khoromi S, Cui L, Nackers L, Max MB.

Pain. 2007 Jul;130(1-2):66-75. Epub 2006 Dec 19.

18.

Symptoms of distress as prospective predictors of pain-related sciatica treatment outcomes.

Edwards RR, Klick B, Buenaver L, Max MB, Haythornthwaite JA, Keller RB, Atlas SJ.

Pain. 2007 Jul;130(1-2):47-55. Epub 2006 Dec 6.

PMID:
17156925
19.

Alcoholism is associated with GALR3 but not two other galanin receptor genes.

Belfer I, Hipp H, Bollettino A, McKnight C, Evans C, Virkkunen M, Albaugh B, Max MB, Goldman D, Enoch MA.

Genes Brain Behav. 2007 Jul;6(5):473-81. Epub 2006 Nov 3.

20.

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.

Turk DC, Dworkin RH, Burke LB, Gershon R, Rothman M, Scott J, Allen RR, Atkinson JH, Chandler J, Cleeland C, Cowan P, Dimitrova R, Dionne R, Farrar JT, Haythornthwaite JA, Hertz S, Jadad AR, Jensen MP, Kellstein D, Kerns RD, Manning DC, Martin S, Max MB, McDermott MP, McGrath P, Moulin DE, Nurmikko T, Quessy S, Raja S, Rappaport BA, Rauschkolb C, Robinson JP, Royal MA, Simon L, Stauffer JW, Stucki G, Tollett J, von Stein T, Wallace MS, Wernicke J, White RE, Williams AC, Witter J, Wyrwich KW; Initiative on Methods, Measurement and Pain Assessment in Clinical Trials.

Pain. 2006 Dec 5;125(3):208-15. Epub 2006 Oct 25. No abstract available.

PMID:
17069973
21.

GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence.

Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lötsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ.

Nat Med. 2006 Nov;12(11):1269-77. Epub 2006 Oct 22.

PMID:
17057711
22.

Effects of chronic osteoarthritis pain on neuroendocrine function in men.

Khoromi S, Muniyappa R, Nackers L, Gray N, Baldwin H, Wong KA, Matheny LA, Moquin B, Rainer A, Hill S, Remaley A, Johnson LL, Max MB, Blackman MR.

J Clin Endocrinol Metab. 2006 Nov;91(11):4313-8. Epub 2006 Aug 15.

PMID:
16912126
23.

Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.

Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W.

Pain. 2006 Dec 5;125(3):216-24. Epub 2006 Jul 11.

PMID:
16837133
24.

Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.

Diatchenko L, Anderson AD, Slade GD, Fillingim RB, Shabalina SA, Higgins TJ, Sama S, Belfer I, Goldman D, Max MB, Weir BS, Maixner W.

Am J Med Genet B Neuropsychiatr Genet. 2006 Jul 5;141B(5):449-62.

25.

Basal heat pain thresholds predict opioid analgesia in patients with postherpetic neuralgia.

Edwards RR, Haythornthwaite JA, Tella P, Max MB, Raja S.

Anesthesiology. 2006 Jun;104(6):1243-8.

PMID:
16732096
27.

A clinical genetic method to identify mechanisms by which pain causes depression and anxiety.

Max MB, Wu T, Atlas SJ, Edwards RR, Haythornthwaite JA, Bollettino AF, Hipp HS, McKnight CD, Osman IA, Crawford EN, Pao M, Nejim J, Kingman A, Aisen DC, Scully MA, Keller RB, Goldman D, Belfer I.

Mol Pain. 2006 Apr 19;2:14.

28.

Afterword: five steps to increase the payoff of chronic pain trials.

Max MB.

Neurology. 2005 Dec 29;65(12 Suppl 4):S74-7. No abstract available.

PMID:
16385108
29.

Topiramate in chronic lumbar radicular pain.

Khoromi S, Patsalides A, Parada S, Salehi V, Meegan JM, Max MB.

J Pain. 2005 Dec;6(12):829-36.

PMID:
16326371
30.

Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations.

Belfer I, Hipp H, McKnight C, Evans C, Buzas B, Bollettino A, Albaugh B, Virkkunen M, Yuan Q, Max MB, Goldman D, Enoch MA.

Mol Psychiatry. 2006 Mar;11(3):301-11.

31.

Combination pharmacotherapy for neuropathic pain: current evidence and future directions.

Gilron I, Max MB.

Expert Rev Neurother. 2005 Nov;5(6):823-30. Review.

PMID:
16274339
32.

Haplotype-based analysis of alpha 2A, 2B, and 2C adrenergic receptor genes captures information on common functional loci at each gene.

Belfer I, Buzas B, Hipp H, Phillips G, Taubman J, Lorincz I, Evans C, Lipsky RH, Enoch MA, Max MB, Goldman D.

J Hum Genet. 2005;50(1):12-20. Epub 2004 Dec 8.

PMID:
15592690
33.

Genetic basis for individual variations in pain perception and the development of a chronic pain condition.

Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W.

Hum Mol Genet. 2005 Jan 1;14(1):135-43. Epub 2004 Nov 10.

PMID:
15537663
34.

Haplotype structure of the beta adrenergic receptor genes in US Caucasians and African Americans.

Belfer I, Buzas B, Evans C, Hipp H, Phillips G, Taubman J, Lorincz I, Lipsky RH, Enoch MA, Max MB, Goldman D.

Eur J Hum Genet. 2005 Mar;13(3):341-51.

35.

Haplotype block and superblock structures of the alpha1-adrenergic receptor genes reveal echoes from the chromosomal past.

Buzas B, Belfer I, Hipp H, Lorincz I, Evans C, Phillips G, Taubman J, Max MB, Goldman D.

Mol Genet Genomics. 2004 Dec;272(5):519-29. Epub 2004 Oct 16.

PMID:
15503142
36.

Haplotype architecture of the norepinephrine transporter gene SLC6A2 in four populations.

Belfer I, Phillips G, Taubman J, Hipp H, Lipsky RH, Enoch MA, Max MB, Goldman D.

J Hum Genet. 2004;49(5):232-45.

PMID:
15362567
37.

Haplotype structure of inflammatory cytokines genes (IL1B, IL6 and TNF/LTA) in US Caucasians and African Americans.

Belfer I, Buzas B, Hipp H, Dean M, Evans C, Lorincz I, Max MB, Goldman D.

Genes Immun. 2004 Sep;5(6):505-12.

PMID:
15306845
38.

Pain in Parkinson disease.

Buzas B, Max MB.

Neurology. 2004 Jun 22;62(12):2156-7. No abstract available.

PMID:
15210873
39.

Candidate gene studies of human pain mechanisms: methods for optimizing choice of polymorphisms and sample size.

Belfer I, Wu T, Kingman A, Krishnaraju RK, Goldman D, Max MB.

Anesthesiology. 2004 Jun;100(6):1562-72. No abstract available.

PMID:
15166579
40.

Assessing pain candidate gene studies.

Max MB.

Pain. 2004 May;109(1-2):1-3. No abstract available.

PMID:
15082119
41.

Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.

Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM.

Arch Neurol. 2003 Nov;60(11):1524-34. Review.

PMID:
14623723
42.
43.

How to move pain and symptom research from the margin to the mainstream.

Max MB.

J Pain. 2003 Sep;4(7):355-60. Review.

PMID:
14622677
44.

An old acquaintance: opioids in neuropathic pain.

Zochodne DW, Max MB.

Neurology. 2003 Mar 25;60(6):894-5. No abstract available.

PMID:
12654949
45.
46.

Clinical evaluation of patients with temporomandibular joint implants.

Ta LE, Phero JC, Pillemer SR, Hale-Donze H, McCartney-Francis N, Kingman A, Max MB, Gordon SM, Wahl SM, Dionne RA.

J Oral Maxillofac Surg. 2002 Dec;60(12):1389-99.

PMID:
12464999
47.

Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial.

Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, Royall RM, Max MB.

Neurology. 2002 Oct 8;59(7):1015-21.

PMID:
12370455
48.
49.

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials.

Sang CN, Booher S, Gilron I, Parada S, Max MB.

Anesthesiology. 2002 May;96(5):1053-61.

PMID:
11981142
50.

Clarifying the definition of neuropathic pain.

Max MB.

Pain. 2002 Apr;96(3):406-7; author reply 407-8. No abstract available.

PMID:
11973017

Supplemental Content

Support Center